Case studies with mrgsolve: PBPK and QSP model implementation and utilization in R
================

Where / when
------------

-   **University at Buffalo**
    -   2018 CDSE Days (Buffalo, NY)
    -   Tuesday, 10 April 9:30 am to 12:30 pm
-   **University of Florida**
    -   College of Pharmacy (Orlando Lake Nona Campus)
    -   Saturday, 24 March 1:30 pm to 5:30 pm

Case Studies
------------

Please see the reading list below for references for the case studies

![](docs/img/README-unnamed-chunk-1-1.png)

**QSP Models**

-   [ERK inhibition in BRAF(V600E) mutant colorectal cancer](docs/mapk_inhibitors_in_colorectal_cancer.md)
-   [OpenBoneMin: Bone marker and BMD changes under denosumab therapy](docs/OpenBoneMin.md)

**PBPK Models**

-   [PBPK model for rifampicin / midazolam DDI](docs/rifampin_midazolam_ddi.md)
-   [Parameter optimization in PBPK model for statin/CsA DDI](docs/oatp_ddi_optimization.md)

**Methods**

-   [Global sensitivity analysis](docs/global_sensitivity_analysis.md)

Reading List
------------

-   **Quantitative Analyses of Hepatic OATP-Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method**
    -   Yoshikado T, Yoshida K, Kotani N, Nakada T, Asaumi R, Toshimoto K, Maeda K, Kusuhara H, Sugiyama Y. Clin Pharmacol Ther. 2016 Nov;100(5):513-523. PMID: 27170342
    -   <https://www.ncbi.nlm.nih.gov/pubmed/27170342>
-   **Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects**
    -   Asaumi R, Toshimoto K, Tobe Y, Hashizume K, Nunoya KI, Imawaka H, Lee W, Sugiyama Y. CPT Pharmacometrics Syst Pharmacol. 2018 Jan 25. PMID: 29368402
    -   <https://www.ncbi.nlm.nih.gov/pubmed/29368402>
-   **Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model**
    -   Kirouac DC, Schaefer G, Chan J, Merchant M, Orr C, Huang SA, Moffat J, Liu L, Gadkar K, Ramanujan S. NPJ Syst Biol Appl. 2017 Jun 2;3:14. PubMed PMID: 28649441
    -   <https://www.ncbi.nlm.nih.gov/pubmed/28649441>
-   **Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology model**
    -   Peterson MC, Riggs MM. CPT Pharmacometrics Syst Pharmacol. 2012 Nov 14;1:e14. PMID: 23835796
    -   <https://www.ncbi.nlm.nih.gov/pubmed/23835796>
-   **Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models**
    -   Zhang XY, Trame MN, Lesko LJ, Schmidt S. . CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):69-79.
        PMID: 27548289
    -   <https://www.ncbi.nlm.nih.gov/pubmed/27548289>
